Tianjin Ruipu Biotechnology’s treatment is still good, and its average salary reaches 21.7k, which is 113% higher than other companies in the same region.
The Ruipu biological products industry is based on high-end genetic engineering, cell engineering, fermentation engineering and other technologies, and develops and produces products for poultry. , biological pharmaceutical products for the prevention, treatment and diagnosis of livestock, dairy cattle and pet diseases, including inactivated vaccines, live vaccines, diagnostic reagents (kits), genetically engineered vaccines, synthetic peptide vaccines, animal antibodies, etc.
